Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines

被引:88
作者
Georges, JL
Rupprecht, HJ
Blankenberg, S
Poirier, O
Bickel, C
Hafner, G
Nicaud, V
Meyer, J
Cambien, FO
Tiret, L
机构
[1] Fac Med, INSERM, U525, F-75634 Paris 13, France
[2] Johannes Gutenberg Univ Mainz, Dept Med 2, D-6500 Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Dept Clin Chem, D-6500 Mainz, Germany
关键词
D O I
10.1016/S0002-9149(03)00717-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The number of infectious pathogens to which an individual has been exposed (pathogen burden) has been linked to the development and the prognosis of coronary artery disease (CAD). The interaction among infection, genetic host susceptibility, and CAD remains unclear. This study was aimed at evaluating the modulation of the association between CAD and pathogen burden, by serum levels of inflammatory markers and polymorphisms of the interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha genes. Immmunoglobulin (Ig) G or IgA antibodies to 8 pathogens were determined in 991 patients with CAD and 333 control subjects. Serum levels of high-sensitivity C-reactive protein, fibrinogen, IL-6, and TNF-alpha were also measured. All subjects were genotyped for the IL-6/G-174C, the TNF/C-851T, and the TNF/G308A polymorphisms. Analysis of single pathogens demonstrated a positive relation to the presence of CAD for some (Chlamydia pneumoniae, cytomegalovirus, Helicobacter pylori, and herpes virus simplex type 1), but not all pathogens. A strong association between increasing pathogen burden and CAD was confirmed, even after adjustment for risk factors. The prevalence of a high pathogen burden (greater than or equal to4 pathogens) was 50% in patients and 21% in controls (p <0.0001). A high pathogen burden was associated with decreased high-density lipoprotein cholesterol levels (p <0.001). The association between CAD and pathogen burden was modulated by the IL6/G-174C polymorphism, the odds ratio being higher in heterozygotes than in both types of homozygotes (p <0.05). This interaction appeared to be mediated by variations in serum IL-6 levels. No such interaction was detected with any of the 2 TNF-alpha polymorphisms. (C) 2003 by Excerpts Medics, Inc.
引用
收藏
页码:515 / 521
页数:7
相关论文
共 26 条
[1]   Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction [J].
Anderson, JL ;
Carlquist, JF ;
Muhlestein, JB ;
Horne, BD ;
Elmer, SP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) :35-41
[2]   Interleukin-6 -174G&gt;C polymorphism and risk of coronary heart disease in West of Scotland Coronary Prevention Study (WOSCOPS) [J].
Basso, F ;
Lowe, GDO ;
Rumley, A ;
McMahon, AD ;
Humphries, SE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :599-604
[3]   Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease [J].
Blankenberg, S ;
Rupprecht, HJ ;
Bickel, C ;
Espinola-Klein, C ;
Rippin, G ;
Hafner, G ;
Ossendorf, M ;
Steinhagen, K ;
Meyer, J .
CIRCULATION, 2001, 103 (24) :2915-2921
[4]   Interleukin-6 gene -174G &gt; C and -572G &gt; C promoter polymorphisms are strong predictors of plasma -: Interleukin-6 levels after coronary artery bypass surgery [J].
Brull, DJ ;
Montgomery, HE ;
Sanders, J ;
Dhamrait, S ;
Luong, L ;
Rumley, A ;
Lowe, GDO ;
Humphries, SE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (09) :1458-1463
[5]   Sequence diversity in 36 candidate genes for cardiovascular disorders [J].
Cambien, F ;
Poirier, O ;
Nicaud, V ;
Herrmann, SM ;
Mallet, C ;
Ricard, S ;
Behague, I ;
Hallet, V ;
Blanc, H ;
Loukaci, V ;
Thillet, J ;
Evans, A ;
Ruidavets, JB ;
Arveiler, D ;
Luc, G ;
Tiret, L .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (01) :183-191
[6]  
DANESH J, 1998, JAMA-J AM MED ASSOC, P1477
[7]   Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient mice [J].
Elhage, R ;
Clamens, S ;
Besnard, S ;
Mallat, Z ;
Tedgui, A ;
Arnal, JF ;
Maret, A ;
Bayard, F .
ATHEROSCLEROSIS, 2001, 156 (02) :315-320
[8]   Infection and atherosclerosis - Emerging mechanistic paradigms [J].
Epstein, SE ;
Zhou, YF ;
Zhu, JH .
CIRCULATION, 1999, 100 (04) :E20-E28
[9]   Impact of infectious burden on extent and long-term prognosis of atherosclerosis [J].
Espinola-Klein, C ;
Rupprecht, HJ ;
Blankenberg, S ;
Bickel, C ;
Kopp, H ;
Rippin, G ;
Victor, A ;
Hafner, G ;
Schlumberger, W ;
Meyer, J .
CIRCULATION, 2002, 105 (01) :15-21
[10]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376